Myocardial Solutions raised $5 million in a new round of equity financing, according to an SEC filing posted today.
Money in the round came from 37 unnamed investors, with the 1st sale recorded on June 30, according to the filing. The company is not seeking anymore funds in the round, and has not yet stated how it plans to spend funds raised.
Myocardial Solutions specified that other than salaries, benefits and other compensation, no directors, officers or promoters will receive any proceeds from the offering, according to an SEC filing.
The funds come hot on the heels of the company’s $4 million Series A round, which closed on June 1. Funds from the Series A went to support its SENC diagnostic software application designed for post-processing of cardiac magnetic resonance imaging.
The Raleigh, N.C.-based company claims the software can reduce patient time within MRI machines from a historical 20-60 minutes to less than 5 minutes and can produce objective results without the need for contrast media, breath holding or radiation.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.